Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 788 across all filing types
Latest filing 2023-09-06 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于部分监事、高级管理人员减持计划期限届满未减持股份的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the expiration of the shareholding reduction period for certain supervisors and senior management personnel, stating that no shares were sold during the planned period. It includes details about the shareholding percentages and compliance with relevant securities laws and regulations. This type of document reports on personal share transactions or intentions thereof by company directors and executives. It is not a financial report, earnings release, or general regulatory filing but specifically relates to insider share transactions. Therefore, it fits the category of Director's Dealing (DIRS). The document length is short and focused solely on this topic, confirming the classification.
2023-09-06 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the third meeting of the fourth Supervisory Board of Kangtai Medical System (Qinhuangdao) Co., Ltd. It includes details about the meeting attendance, the approval of the 2023 semi-annual report and its summary, and the approval of a special report on the use of raised funds for the first half of 2023. The document is an official announcement of meeting resolutions and approvals rather than the report itself. It is relatively short (888 characters) and does not contain the full semi-annual report or detailed financial statements. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-08-29 Chinese
2023年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2023 半年度报告摘要' which translates to '2023 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, asset and liability ratios, and shareholder information for the half-year period. The presence of comprehensive financial metrics and accounting data indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3078 characters, which is relatively short but contains substantive financial data, not just an announcement or summary notice. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-29 Chinese
关于2023年半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised by the company through stock issuance and convertible bonds. It includes specifics on amounts raised, usage, balances, changes in project funding, and compliance with regulatory requirements. The document references regulatory approvals, audit reports, and includes detailed tables of fund usage and project progress. It is titled as a "专项报告" (special report) on the use and storage of raised funds for the half-year period of 2023. This type of document corresponds to a Capital/Financing Update, as it focuses on fundraising activities, fund management, and usage rather than a full annual or interim financial report. It is not an announcement of a report publication but the report itself, given its length and detailed content.
2023-08-29 Chinese
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fourth meeting of the fourth board of directors of 康泰医学系统（秦皇岛）股份有限公司. It includes details about the meeting date, attendance, and voting results. The key agenda items were the approval of the company's 2023 semi-annual report and a special report on the use of raised funds. However, the document itself does not contain the full semi-annual report or the detailed financial data; instead, it references that these reports are published on an external website (巨潮资讯网). The document is primarily a board meeting resolution announcement and does not contain substantive financial statements or analysis. Given the short length (1268 characters) and the nature of the content, this fits the category of a Regulatory Filing (RNS) as it is an official announcement related to corporate governance and disclosures but not the report itself.
2023-08-29 Chinese
独立董事关于第四届董事会第四次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the fourth meeting of the fourth board of directors, specifically regarding the 2023 semi-annual report on the use of raised funds and the situation of related party fund occupation and external guarantees. It references regulatory guidelines and laws related to corporate governance and fund management. The content is a formal opinion on governance and compliance matters rather than a full financial report or earnings release. It is not a general announcement or a brief notice but a detailed governance-related opinion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements related to board activities and management opinions.
2023-08-29 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.